MDGL vs. KBH

In the year-to-date period, MDGL achieves a -10.79% return, which is significantly higher than KBH's -20.85% return. Over the past 10 years, MDGL has underperformed KBH with an annualized return of 13.48%, while KBH has yielded a comparatively higher 14.71% annualized return.

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.

This table presents a comparison of risk-adjusted performance metrics for Madrigal Pharmaceuticals, Inc. (MDGL) and KB Home (KBH). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

The current MDGL Sharpe Ratio is 0.37, which is higher than the KBH Sharpe Ratio of -0.69. The chart below compares the historical Sharpe Ratios of MDGL and KBH, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.

MDGL has not paid dividends to shareholders, while KBH's dividend yield for the trailing twelve months is around 1.94%.

The maximum MDGL drawdown since its inception was -98.40%, which is greater than KBH's maximum drawdown of -92.78%. Use the drawdown chart below to compare losses from any high point for MDGL and KBH.

Madrigal Pharmaceuticals, Inc. (MDGL) and KB Home (KBH) have volatilities of 10.56% and 10.23%, respectively, indicating that both stocks experience similar levels of price fluctuations. This suggests that the risk associated with both stocks, as measured by volatility, is nearly the same. The chart below showcases a comparison of their rolling one-month volatility.

This section allows you to compare key financial metrics between Madrigal Pharmaceuticals, Inc. and KB Home. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.